Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.
Valeriani M, Detti B, Fodor A, Caini S, Borghesi S, Trippa F, Triggiani L, Bruni A, Russo D, Saldi S, Di Staso M, Francolini G, Lancia A, Marinelli L, Di Muzio N, Aristei C, Livi L, Magrini SM, Ingrosso G.
Valeriani M, et al. Among authors: borghesi s.
Radiol Med. 2022 Jan;127(1):108-116. doi: 10.1007/s11547-021-01424-x. Epub 2021 Nov 8.
Radiol Med. 2022.
PMID: 34748151